Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0023418 (leukemia)
 93,477 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The Third International Symposium on Immunotoxins was held on June 19-21, 1992 in Orlando, Florida. This symposium was sponsored by NATO, NIH, Pierce Chemical Company, Walt Disney Cancer Institute at Florida Hospital, Duke Comprehensive Cancer Center, Xoma, Immunogen, Seragen, Bristol-Myers Squibb, Chiron, Ortho Biotech, Upjohn, Merck Sharp & Dohme Research Laboratories, Abbot Laboratories, Lilly Research Laboratories, and Evans & Sutherland. The Pierce Immunotoxin Award which recognizes outstanding contributions to immunotoxin research and development, was presented to Drs David FitzGerald, Fatih Uckun, David Eisenberg, and Ira Wool, for their contributions to the immunotoxin field.
Leukemia 1993 Feb
PMID:The current status of immunotoxins: an overview of experimental and clinical studies as presented at the Third International Symposium on Immunotoxins. 809 12

Samir Hanash is a pioneer in cancer proteomics and was elected as the Inaugural President of the Human Proteome Organization (HUPO) in June 2001. He is Professor of Medicine at the University of Michigan (UM) where he heads a large research group that focuses on cancer proteomics, and is also on the executive committees of several research associations, including the American Society for Cell Biology (ASCB) and the American Association for Cancer Research (AACR). After obtaining a medical degree in 1972 from American University in Beirut, Lebanon, Hanash moved to UM where he studied for his PhD on haemoglobin protein and gene analysis in the Human Genetics department and was awarded the Public Health Service (PHS) Fellowship award in Biochemical Genetics in 1975. After a post-doctoral fellowship in the same department, Hanash took up a Residency position in Pediatrics at the Children's Hospital of Michigan, during which time he was awarded a Children's Leukaemia Foundation Fellowship Award. Subsequently, he has held the positions of Instructor in Pediatric Hematology (1978-1979), and Assistant Professor (1979-1984) and Associate Professor (1984-1989) of Pediatrics before taking on his present role as Professor of Pediatrics at UM. He is also Director of the Cancer Center Carcinogenesis Program and a member of the Gene Therapy Group and the Genome Center and Computer Task Force at UM. He was awarded the Rothchild Award by the Curie Cancer Institute in 1998. [interview by Joanna Owens]
 ...
PMID:Samir Hanash discusses how HUPO aims to globalize proteomics research (interview by Joanna Owens). 1254 63

Professor John Gribben is Chair of the International Workshop on non-Hodgkin Lymphoma and the Gordon Hamilton Fairley Chair of Medical Oncology at St. Bartholomew's Hospital, Bart's Cancer Institute, London, UK, a Cancer Research UK Centre of Excellence. His doctoral studies were performed at University College London, UK as the recipient of a Wellcome Trust Fellowship Award and he continued post-doctoral training with Professor Lee Nadler at the Dana-Farber Cancer Institute (Harvard Medical School, MA, USA). In 1992, Gribben was appointed to the Faculty at Harvard Medical School, where he remained as Associate Professor of Medicine and an Attending Physician at the Dana-Farber Cancer Institute and Brigham and Women's Hospital (MA, USA), until returning to London in 2005. Gribben is a founding member of the CLL Research Consortium, Associate Editor of Blood and was elected a Fellow of the Academy of Medical Science. His primary research interests include the immunotherapy of cancer (including stem cell transplantation), the identification of B-cell-tumor antigens and the detection and treatment of minimal residual disease in leukemia and lymphoma.
 ...
PMID:Bendamustine for non-Hodgkin lymphoma. Interview by Louise Rishton. 2354 60

Connie Eaves sets high standards for herself, her science, and her colleagues, which has fueled a stellar career that counts as successes insights into basic stem cell biology, important discoveries in leukemia and breast cancer, and a cohort of trainees that she considers family. Cell editor Lara Szewczak caught up with Connie, the recipient of the 2019 Canada Gairdner Wightman Award, to discuss her dual passions for stem cell biology and mentoring talented young scientists. Annotated excerpts from this conversation are presented below.
 ...
PMID:Evolving as a Scientist and a Mentor. 3095 44